The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was named:

"
Cystine-knot cytokines
".

Functional Families

Overview of the Structural Clusters (SC) and Functional Families within this CATH Superfamily. Clusters with a representative structure are represented by a filled circle.
« Back to all FunFams

FunFam 9: Vascular endothelial growth factor A

Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.

There are 46 GO terms relating to "molecular function"

The search results have been sorted with the annotations that are found most frequently at the top of the list. The results can be filtered by typing text into the search box at the top of the table.
GO Term Annotations Evidence
Cytokine activity GO:0005125
Functions to control the survival, growth, differentiation and effector function of tissues and cells.
26 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(16 more)
Growth factor activity GO:0008083
The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation.
26 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(16 more)
Fibronectin binding GO:0001968
Interacting selectively and non-covalently with a fibronectin, a group of related adhesive glycoproteins of high molecular weight found on the surface of animal cells, connective tissue matrices, and in extracellular fluids.
23 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(13 more)
Platelet-derived growth factor receptor binding GO:0005161
Interacting selectively and non-covalently with the platelet-derived growth factor receptor.
23 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(13 more)
Vascular endothelial growth factor receptor binding GO:0005172
Interacting selectively and non-covalently with any vascular endothelial growth factor receptor.
23 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(13 more)
Heparin binding GO:0008201
Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.
23 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(13 more)
Chemoattractant activity GO:0042056
Providing the environmental signal that initiates the directed movement of a motile cell or organism towards a higher concentration of that signal.
23 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(13 more)
Vascular endothelial growth factor receptor 1 binding GO:0043183
Interacting selectively and non-covalently with vascular endothelial growth factor receptor 1.
23 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(13 more)
Vascular endothelial growth factor receptor 2 binding GO:0043184
Interacting selectively and non-covalently with vascular endothelial growth factor receptor 2.
23 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(13 more)
Receptor ligand activity GO:0048018
The activity of a gene product that interacts with a receptor to effect a change in the activity of the receptor. Ligands may be produced by the same, or different, cell that expresses the receptor. Ligands may diffuse extracellularly from their point of origin to the receiving cell, or remain attached to an adjacent cell surface (e.g. Notch ligands).
23 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(13 more)
Growth factor activity GO:0008083
The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation.
7 P15691 (/IDA) P15691 (/IDA) P15691 (/IDA) P15692 (/IDA) P15692 (/IDA) P15692 (/IDA) P16612 (/IDA)
Cytokine activity GO:0005125
Functions to control the survival, growth, differentiation and effector function of tissues and cells.
6 P15691 (/IDA) P15691 (/IDA) P15691 (/IDA) P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
4 P15692 (/IPI) P15692 (/IPI) P15692 (/IPI) Q00731 (/IPI)
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
4 P15691 (/IDA) P15691 (/IDA) P15691 (/IDA) P16612 (/IDA)
Fibronectin binding GO:0001968
Interacting selectively and non-covalently with a fibronectin, a group of related adhesive glycoproteins of high molecular weight found on the surface of animal cells, connective tissue matrices, and in extracellular fluids.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Platelet-derived growth factor receptor binding GO:0005161
Interacting selectively and non-covalently with the platelet-derived growth factor receptor.
3 P15692 (/IPI) P15692 (/IPI) P15692 (/IPI)
Vascular endothelial growth factor receptor binding GO:0005172
Interacting selectively and non-covalently with any vascular endothelial growth factor receptor.
3 P15692 (/IPI) P15692 (/IPI) P15692 (/IPI)
Heparin binding GO:0008201
Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Heparin binding GO:0008201
Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.
3 P15692 (/IMP) P15692 (/IMP) P15692 (/IMP)
Chemoattractant activity GO:0042056
Providing the environmental signal that initiates the directed movement of a motile cell or organism towards a higher concentration of that signal.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
3 P15692 (/IPI) P15692 (/IPI) P15692 (/IPI)
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
3 P15692 (/ISS) P15692 (/ISS) P15692 (/ISS)
Vascular endothelial growth factor receptor 1 binding GO:0043183
Interacting selectively and non-covalently with vascular endothelial growth factor receptor 1.
3 P15692 (/IPI) P15692 (/IPI) P15692 (/IPI)
Vascular endothelial growth factor receptor 2 binding GO:0043184
Interacting selectively and non-covalently with vascular endothelial growth factor receptor 2.
3 P15692 (/IPI) P15692 (/IPI) P15692 (/IPI)
Protein heterodimerization activity GO:0046982
Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Receptor ligand activity GO:0048018
The activity of a gene product that interacts with a receptor to effect a change in the activity of the receptor. Ligands may be produced by the same, or different, cell that expresses the receptor. Ligands may diffuse extracellularly from their point of origin to the receiving cell, or remain attached to an adjacent cell surface (e.g. Notch ligands).
3 P15692 (/IPI) P15692 (/IPI) P15692 (/IPI)
Extracellular matrix binding GO:0050840
Interacting selectively and non-covalently with a component of the extracellular matrix.
3 P15692 (/IC) P15692 (/IC) P15692 (/IC)
Fibronectin binding GO:0001968
Interacting selectively and non-covalently with a fibronectin, a group of related adhesive glycoproteins of high molecular weight found on the surface of animal cells, connective tissue matrices, and in extracellular fluids.
1 Q00731 (/ISO)
Cytokine activity GO:0005125
Functions to control the survival, growth, differentiation and effector function of tissues and cells.
1 Q00731 (/ISO)
Platelet-derived growth factor receptor binding GO:0005161
Interacting selectively and non-covalently with the platelet-derived growth factor receptor.
1 Q00731 (/ISO)
Vascular endothelial growth factor receptor binding GO:0005172
Interacting selectively and non-covalently with any vascular endothelial growth factor receptor.
1 Q00731 (/ISO)
Vascular endothelial growth factor receptor binding GO:0005172
Interacting selectively and non-covalently with any vascular endothelial growth factor receptor.
1 P16612 (/TAS)
Growth factor activity GO:0008083
The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation.
1 Q00731 (/ISO)
Heparin binding GO:0008201
Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.
1 Q00731 (/ISO)
Growth factor binding GO:0019838
Interacting selectively and non-covalently with any growth factor, proteins or polypeptides that stimulate a cell or organism to grow or proliferate.
1 P16612 (/IPI)
Growth factor binding GO:0019838
Interacting selectively and non-covalently with any growth factor, proteins or polypeptides that stimulate a cell or organism to grow or proliferate.
1 Q00731 (/ISO)
Neuropilin binding GO:0038191
Interacting selectively and non-covalently with a member of the neuropilin family.
1 Q00731 (/ISO)
Chemoattractant activity GO:0042056
Providing the environmental signal that initiates the directed movement of a motile cell or organism towards a higher concentration of that signal.
1 P16612 (/IMP)
Chemoattractant activity GO:0042056
Providing the environmental signal that initiates the directed movement of a motile cell or organism towards a higher concentration of that signal.
1 Q00731 (/ISO)
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
1 Q00731 (/ISO)
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
1 Q00731 (/ISO)
Vascular endothelial growth factor receptor 1 binding GO:0043183
Interacting selectively and non-covalently with vascular endothelial growth factor receptor 1.
1 Q00731 (/ISO)
Vascular endothelial growth factor receptor 2 binding GO:0043184
Interacting selectively and non-covalently with vascular endothelial growth factor receptor 2.
1 P16612 (/IMP)
Vascular endothelial growth factor receptor 2 binding GO:0043184
Interacting selectively and non-covalently with vascular endothelial growth factor receptor 2.
1 Q00731 (/ISO)
Protein heterodimerization activity GO:0046982
Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
1 Q00731 (/ISO)
Receptor ligand activity GO:0048018
The activity of a gene product that interacts with a receptor to effect a change in the activity of the receptor. Ligands may be produced by the same, or different, cell that expresses the receptor. Ligands may diffuse extracellularly from their point of origin to the receiving cell, or remain attached to an adjacent cell surface (e.g. Notch ligands).
1 Q00731 (/ISO)

There are 307 GO terms relating to "biological process"

The search results have been sorted with the annotations that are found most frequently at the top of the list. The results can be filtered by typing text into the search box at the top of the table.
GO Term Annotations Evidence
Positive regulation of peptidyl-tyrosine phosphorylation GO:0050731
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine.
44 B2C4J6 (/ISS) C0K3N4 (/ISS) C0K3N4 (/ISS) C0K3N4 (/ISS) C0K3N4 (/ISS) C0K3N5 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS)
(34 more)
Positive regulation of endothelial cell proliferation GO:0001938
Any process that activates or increases the rate or extent of endothelial cell proliferation.
43 B2C4J6 (/ISS) C0K3N4 (/ISS) C0K3N4 (/ISS) C0K3N4 (/ISS) C0K3N4 (/ISS) C0K3N5 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS)
(33 more)
Positive regulation of endothelial cell migration GO:0010595
Any process that increases the rate, frequency, or extent of the orderly movement of an endothelial cell into the extracellular matrix to form an endothelium.
35 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(25 more)
Positive regulation of angiogenesis GO:0045766
Any process that activates or increases angiogenesis.
35 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(25 more)
Positive regulation of protein complex assembly GO:0031334
Any process that activates or increases the frequency, rate or extent of protein complex assembly.
25 C0K3N4 (/ISS) C0K3N4 (/ISS) C0K3N4 (/ISS) C0K3N4 (/ISS) C0K3N5 (/ISS) P15691 (/ISS) P15691 (/ISS) P15691 (/ISS) P16612 (/ISS) P26617 (/ISS)
(15 more)
Positive regulation of focal adhesion assembly GO:0051894
Any process that activates or increases the frequency, rate or extent of focal adhesion assembly, the establishment and maturation of focal adhesions.
25 C0K3N4 (/ISS) C0K3N4 (/ISS) C0K3N4 (/ISS) C0K3N4 (/ISS) C0K3N5 (/ISS) P15691 (/ISS) P15691 (/ISS) P15691 (/ISS) P16612 (/ISS) P26617 (/ISS)
(15 more)
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
23 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(13 more)
Cell migration involved in sprouting angiogenesis GO:0002042
The orderly movement of endothelial cells into the extracellular matrix in order to form new blood vessels involved in sprouting angiogenesis.
23 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(13 more)
Positive regulation of receptor internalization GO:0002092
Any process that activates or increases the frequency, rate or extent of receptor internalization.
23 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(13 more)
Regulation of cell shape GO:0008360
Any process that modulates the surface configuration of a cell.
23 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(13 more)
Monocyte differentiation GO:0030224
The process in which a relatively unspecialized myeloid precursor cell acquires the specialized features of a monocyte.
23 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(13 more)
Macrophage differentiation GO:0030225
The process in which a relatively unspecialized monocyte acquires the specialized features of a macrophage.
23 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(13 more)
Positive regulation of vascular endothelial growth factor receptor signaling pathway GO:0030949
Any process that activates or increases the frequency, rate or extent of vascular endothelial growth factor receptor signaling pathway activity.
23 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(13 more)
Positive regulation of protein autophosphorylation GO:0031954
Any process that activates or increases the frequency, rate or extent of the phosphorylation by a protein of one or more of its own residues.
23 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(13 more)
Activation of protein kinase activity GO:0032147
Any process that initiates the activity of an inactive protein kinase.
23 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(13 more)
Positive regulation of CREB transcription factor activity GO:0032793
Any process that activates or increases the frequency, rate or extent of activity of the transcription factor CREB.
23 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(13 more)
Positive regulation of peptidyl-serine phosphorylation GO:0033138
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine.
23 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(13 more)
Endothelial cell chemotaxis GO:0035767
The directed movement of an endothelial cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis).
23 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(13 more)
Cellular response to vascular endothelial growth factor stimulus GO:0035924
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vascular endothelial growth factor stimulus.
23 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(13 more)
Positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway GO:0038033
A series of molecular signals initiated by the binding of a vascular endothelial growth factor (VEGF) to a VEGFR on the surface of a cell, which activates or increases the frequency, rate or extent of endothelial cell chemotaxis.
23 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(13 more)
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
23 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(13 more)
Positive regulation of MAP kinase activity GO:0043406
Any process that activates or increases the frequency, rate or extent of MAP kinase activity.
23 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(13 more)
Positive regulation of blood vessel endothelial cell migration GO:0043536
Any process that activates or increases the frequency, rate or extent of the migration of the endothelial cells of blood vessels.
23 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(13 more)
Positive regulation of cell adhesion GO:0045785
Any process that activates or increases the frequency, rate or extent of cell adhesion.
23 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(13 more)
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
23 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(13 more)
Positive regulation of positive chemotaxis GO:0050927
Any process that activates or increases the frequency, rate or extent of the directed movement of a motile cell or organism towards a higher concentration in a concentration gradient of a specific chemical.
23 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(13 more)
Positive regulation of cellular component movement GO:0051272
Any process that activates or increases the frequency, rate or extent of the movement of a cellular component.
23 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(13 more)
Cellular response to hypoxia GO:0071456
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
23 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(13 more)
Positive regulation of protein kinase C signaling GO:0090037
Any process that increases the frequency, rate, or extent of a series of reactions, mediated by the intracellular serine/threonine kinase protein kinase C, which occurs as a result of a single trigger reaction or compound.
23 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(13 more)
Positive regulation of cell migration involved in sprouting angiogenesis GO:0090050
Any process that increases the frequency, rate or extent of cell migration involved in sprouting angiogenesis. Cell migration involved in sprouting angiogenesis is the orderly movement of endothelial cells into the extracellular matrix in order to form new blood vessels contributing to the process of sprouting angiogenesis.
23 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(13 more)
Positive regulation of peptidyl-tyrosine autophosphorylation GO:1900086
Any process that activates or increases the frequency, rate or extent of peptidyl-tyrosine autophosphorylation.
23 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(13 more)
Angiogenesis GO:0001525
Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
22 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(12 more)
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
22 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(12 more)
Positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway GO:0038091
A series of molecular signals initiated by the binding of a vascular endothelial growth factor (VEGF) to a platelet-derived growth factor receptor (PDGFR) on the surface of a cell, which activates or increases the frequency, rate or extent of cell proliferation.
22 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(12 more)
Vascular endothelial growth factor receptor signaling pathway GO:0048010
Any series of molecular signals initiated by the binding of an extracellular ligand to a vascular endothelial growth factor receptor (VEGFR) located on the surface of the receiving cell, and ending with regulation of a downstream cellular process, e.g. transcription.
22 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(12 more)
Positive regulation of protein kinase D signaling GO:1903572
Any process that activates or increases the frequency, rate or extent of protein kinase D signaling.
22 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(12 more)
Positive regulation of protein phosphorylation GO:0001934
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
16 P15691 (/ISS) P15691 (/ISS) P15691 (/ISS) P16612 (/ISS) P26617 (/ISS) P49151 (/ISS) P49151 (/ISS) P50412 (/ISS) P50412 (/ISS) P67965 (/ISS)
(6 more)
Tube formation GO:0035148
Creation of the central hole of a tube in an anatomical structure through which gases and/or liquids flow.
16 P15691 (/ISS) P15691 (/ISS) P15691 (/ISS) P16612 (/ISS) P26617 (/ISS) P49151 (/ISS) P49151 (/ISS) P50412 (/ISS) P50412 (/ISS) P67965 (/ISS)
(6 more)
Motor neuron migration GO:0097475
The orderly movement of a motor neuron from one site to another. A motor neuron is an efferent neuron that passes from the central nervous system or a ganglion toward or to a muscle and conducts an impulse that causes movement.
16 P15691 (/ISS) P15691 (/ISS) P15691 (/ISS) P15692 (/ISS) P15692 (/ISS) P15692 (/ISS) P16612 (/ISS) P26617 (/ISS) P49151 (/ISS) P49151 (/ISS)
(6 more)
Positive regulation of cold-induced thermogenesis GO:0120162
Any process that activates or increases the frequency, rate or extent of cold-induced thermogenesis.
11 A0A0G2K6Z7 (/ISS) A0A0H2UHY5 (/ISS) B5DEK7 (/ISS) F1M6X1 (/ISS) F8WG85 (/ISS) G8JLS5 (/ISS) P15692 (/ISS) P15692 (/ISS) P15692 (/ISS) P16612 (/ISS)
(1 more)
Positive regulation of endothelial cell proliferation GO:0001938
Any process that activates or increases the rate or extent of endothelial cell proliferation.
6 P15691 (/IDA) P15691 (/IDA) P15691 (/IDA) P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Cellular response to hypoxia GO:0071456
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
6 P15691 (/IDA) P15691 (/IDA) P15691 (/IDA) P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Positive regulation of angiogenesis GO:0045766
Any process that activates or increases angiogenesis.
5 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA) P16612 (/IDA) Q00731 (/IDA)
Angiogenesis GO:0001525
Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
4 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA) Q00731 (/IDA)
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
4 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA) P16612 (/IDA)
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
4 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA) Q00731 (/IDA)
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
4 P15692 (/IMP) P15692 (/IMP) P15692 (/IMP) P16612 (/IMP)
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
4 P15692 (/IMP) P15692 (/IMP) P15692 (/IMP) Q00731 (/IMP)
Positive regulation of vascular permeability GO:0043117
Any process that increases the extent to which blood vessels can be pervaded by fluid.
4 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA) Q00731 (/IDA)
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
4 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA) P16612 (/IDA)
Positive regulation of peptidyl-tyrosine phosphorylation GO:0050731
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine.
4 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA) Q00731 (/IDA)
Positive chemotaxis GO:0050918
The directed movement of a motile cell or organism towards a higher concentration of a chemical.
4 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA) Q00731 (/IDA)
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Ovarian follicle development GO:0001541
The process whose specific outcome is the progression of the ovarian follicle over time, from its formation to the mature structure.
3 P15692 (/ISS) P15692 (/ISS) P15692 (/ISS)
Branching involved in blood vessel morphogenesis GO:0001569
The process of coordinated growth and sprouting of blood vessels giving rise to the organized vascular system.
3 P15692 (/ISS) P15692 (/ISS) P15692 (/ISS)
Vasculogenesis GO:0001570
The differentiation of endothelial cells from progenitor cells during blood vessel development, and the de novo formation of blood vessels and tubes.
3 P15692 (/TAS) P15692 (/TAS) P15692 (/TAS)
In utero embryonic development GO:0001701
The process whose specific outcome is the progression of the embryo in the uterus over time, from formation of the zygote in the oviduct, to birth. An example of this process is found in Mus musculus.
3 P15692 (/ISS) P15692 (/ISS) P15692 (/ISS)
Kidney development GO:0001822
The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine.
3 P15692 (/ISS) P15692 (/ISS) P15692 (/ISS)
Positive regulation of protein phosphorylation GO:0001934
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Cell migration involved in sprouting angiogenesis GO:0002042
The orderly movement of endothelial cells into the extracellular matrix in order to form new blood vessels involved in sprouting angiogenesis.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Positive regulation of neuroblast proliferation GO:0002052
Any process that activates or increases the rate of neuroblast proliferation.
3 P15692 (/ISS) P15692 (/ISS) P15692 (/ISS)
Positive regulation of mesenchymal cell proliferation GO:0002053
The process of activating or increasing the rate or extent of mesenchymal cell proliferation. Mesenchymal cells are loosely organized embryonic cells.
3 P15692 (/ISS) P15692 (/ISS) P15692 (/ISS)
Positive regulation of receptor internalization GO:0002092
Any process that activates or increases the frequency, rate or extent of receptor internalization.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Platelet degranulation GO:0002576
The regulated exocytosis of secretory granules containing preformed mediators such as histamine and serotonin by a platelet.
3 P15692 (/TAS) P15692 (/TAS) P15692 (/TAS)
Positive regulation of leukocyte migration GO:0002687
Any process that activates or increases the frequency, rate, or extent of leukocyte migration.
3 P15692 (/TAS) P15692 (/TAS) P15692 (/TAS)
Heart morphogenesis GO:0003007
The developmental process in which the heart is generated and organized. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
3 P15692 (/ISS) P15692 (/ISS) P15692 (/ISS)
Outflow tract morphogenesis GO:0003151
The process in which the anatomical structures of the outflow tract are generated and organized. The outflow tract is the portion of the heart through which blood flows into the arteries.
3 P15692 (/ISS) P15692 (/ISS) P15692 (/ISS)
Coronary vein morphogenesis GO:0003169
The process in which the anatomical structures of veins of the heart are generated and organized.
3 P15692 (/ISS) P15692 (/ISS) P15692 (/ISS)
Regulation of transcription by RNA polymerase II GO:0006357
Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.
3 P15692 (/TAS) P15692 (/TAS) P15692 (/TAS)
Nervous system development GO:0007399
The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state.
3 P15692 (/TAS) P15692 (/TAS) P15692 (/TAS)
Mesoderm development GO:0007498
The process whose specific outcome is the progression of the mesoderm over time, from its formation to the mature structure. The mesoderm is the middle germ layer that develops into muscle, bone, cartilage, blood and connective tissue.
3 P15692 (/ISS) P15692 (/ISS) P15692 (/ISS)
Lactation GO:0007595
The regulated release of milk from the mammary glands and the period of time that a mother lactates to feed her young.
3 P15692 (/ISS) P15692 (/ISS) P15692 (/ISS)
Regulation of cell shape GO:0008360
Any process that modulates the surface configuration of a cell.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Positive regulation of endothelial cell migration GO:0010595
Any process that increases the rate, frequency, or extent of the orderly movement of an endothelial cell into the extracellular matrix to form an endothelium.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Negative regulation of gene expression GO:0010629
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Regulation of nitric oxide mediated signal transduction GO:0010749
Any process that modulates the rate, frequency or extent of nitric oxide mediated signal transduction. Nitric oxide mediated signal transduction is a series of molecular signals mediated by the detection of nitric oxide (NO).
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Cytokine-mediated signaling pathway GO:0019221
A series of molecular signals initiated by the binding of a cytokine to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
3 P15692 (/TAS) P15692 (/TAS) P15692 (/TAS)
Monocyte differentiation GO:0030224
The process in which a relatively unspecialized myeloid precursor cell acquires the specialized features of a monocyte.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Macrophage differentiation GO:0030225
The process in which a relatively unspecialized monocyte acquires the specialized features of a macrophage.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Lung development GO:0030324
The process whose specific outcome is the progression of the lung over time, from its formation to the mature structure. In all air-breathing vertebrates the lungs are developed from the ventral wall of the oesophagus as a pouch which divides into two sacs. In amphibians and many reptiles the lungs retain very nearly this primitive sac-like character, but in the higher forms the connection with the esophagus becomes elongated into the windpipe and the inner walls of the sacs become more and more divided, until, in the mammals, the air spaces become minutely divided into tubes ending in small air cells, in the walls of which the blood circulates in a fine network of capillaries. In mammals the lungs are more or less divided into lobes, and each lung occupies a separate cavity in the thorax.
3 P15692 (/ISS) P15692 (/ISS) P15692 (/ISS)
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Epithelial cell differentiation GO:0030855
The process in which a relatively unspecialized cell acquires specialized features of an epithelial cell, any of the cells making up an epithelium.
3 P15692 (/ISS) P15692 (/ISS) P15692 (/ISS)
Positive regulation of vascular endothelial growth factor receptor signaling pathway GO:0030949
Any process that activates or increases the frequency, rate or extent of vascular endothelial growth factor receptor signaling pathway activity.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Post-embryonic camera-type eye development GO:0031077
The process occurring during the post-embryonic phase whose specific outcome is the progression of the camera-type eye over time, from its formation to the mature structure.
3 P15692 (/ISS) P15692 (/ISS) P15692 (/ISS)
Positive regulation of protein complex assembly GO:0031334
Any process that activates or increases the frequency, rate or extent of protein complex assembly.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Positive regulation of protein autophosphorylation GO:0031954
Any process that activates or increases the frequency, rate or extent of the phosphorylation by a protein of one or more of its own residues.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Activation of protein kinase activity GO:0032147
Any process that initiates the activity of an inactive protein kinase.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Positive regulation of CREB transcription factor activity GO:0032793
Any process that activates or increases the frequency, rate or extent of activity of the transcription factor CREB.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Positive regulation of peptidyl-serine phosphorylation GO:0033138
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Tube formation GO:0035148
Creation of the central hole of a tube in an anatomical structure through which gases and/or liquids flow.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Endothelial cell chemotaxis GO:0035767
The directed movement of an endothelial cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis).
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Cellular response to vascular endothelial growth factor stimulus GO:0035924
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vascular endothelial growth factor stimulus.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Lymph vessel morphogenesis GO:0036303
The process in which the anatomical structures of lymph vessels are generated and organized. The lymph vessel is the vasculature carrying lymph.
3 P15692 (/ISS) P15692 (/ISS) P15692 (/ISS)
Positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway GO:0038033
A series of molecular signals initiated by the binding of a vascular endothelial growth factor (VEGF) to a VEGFR on the surface of a cell, which activates or increases the frequency, rate or extent of endothelial cell chemotaxis.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway GO:0038091
A series of molecular signals initiated by the binding of a vascular endothelial growth factor (VEGF) to a platelet-derived growth factor receptor (PDGFR) on the surface of a cell, which activates or increases the frequency, rate or extent of cell proliferation.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
VEGF-activated neuropilin signaling pathway GO:0038190
A series of molecular signals initiated by the binding of vascular endothelial growth factor (VEGF) to a neuropilin protein on the surface of a target cell, followed by transmission of the signal, and ending with regulation of a downstream cellular process, e.g. transcription.
3 P15692 (/ISS) P15692 (/ISS) P15692 (/ISS)
Eye photoreceptor cell development GO:0042462
Development of a photoreceptor, a sensory cell in the eye that reacts to the presence of light. They usually contain a pigment that undergoes a chemical change when light is absorbed, thus stimulating a nerve.
3 P15692 (/ISS) P15692 (/ISS) P15692 (/ISS)
Surfactant homeostasis GO:0043129
Any process involved in the maintenance of a steady-state level of the surface-active lipoprotein mixture which coats the alveoli.
3 P15692 (/ISS) P15692 (/ISS) P15692 (/ISS)
Negative regulation of cysteine-type endopeptidase activity involved in apoptotic process GO:0043154
Any process that stops, prevents, or reduces the frequency, rate or extent of a cysteine-type endopeptidase activity involved in the apoptotic process.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Positive regulation of MAP kinase activity GO:0043406
Any process that activates or increases the frequency, rate or extent of MAP kinase activity.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Positive regulation of blood vessel endothelial cell migration GO:0043536
Any process that activates or increases the frequency, rate or extent of the migration of the endothelial cells of blood vessels.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Positive regulation of angiogenesis GO:0045766
Any process that activates or increases angiogenesis.
3 P15692 (/IMP) P15692 (/IMP) P15692 (/IMP)
Positive regulation of cell adhesion GO:0045785
Any process that activates or increases the frequency, rate or extent of cell adhesion.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
3 P15692 (/IMP) P15692 (/IMP) P15692 (/IMP)
Vascular endothelial growth factor receptor signaling pathway GO:0048010
Any series of molecular signals initiated by the binding of an extracellular ligand to a vascular endothelial growth factor receptor (VEGFR) located on the surface of the receiving cell, and ending with regulation of a downstream cellular process, e.g. transcription.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Vascular endothelial growth factor receptor signaling pathway GO:0048010
Any series of molecular signals initiated by the binding of an extracellular ligand to a vascular endothelial growth factor receptor (VEGFR) located on the surface of the receiving cell, and ending with regulation of a downstream cellular process, e.g. transcription.
3 P15692 (/TAS) P15692 (/TAS) P15692 (/TAS)
Cell maturation GO:0048469
A developmental process, independent of morphogenetic (shape) change, that is required for a cell to attain its fully functional state.
3 P15692 (/ISS) P15692 (/ISS) P15692 (/ISS)
Camera-type eye morphogenesis GO:0048593
The process in which the anatomical structures of the eye are generated and organized. The camera-type eye is an organ of sight that receives light through an aperture and focuses it through a lens, projecting it on a photoreceptor field.
3 P15692 (/ISS) P15692 (/ISS) P15692 (/ISS)
Cardiac muscle fiber development GO:0048739
The process whose specific outcome is the progression of cardiac muscle fiber over time, from its formation to the mature structure.
3 P15692 (/ISS) P15692 (/ISS) P15692 (/ISS)
Branching morphogenesis of an epithelial tube GO:0048754
The process in which the anatomical structures of branches in an epithelial tube are generated and organized. A tube is a long hollow cylinder.
3 P15692 (/ISS) P15692 (/ISS) P15692 (/ISS)
Positive regulation of axon extension involved in axon guidance GO:0048842
Any process that activates, maintains or increases the frequency, rate or extent of axon extension involved in axon guidance.
3 P15692 (/ISS) P15692 (/ISS) P15692 (/ISS)
Artery morphogenesis GO:0048844
The process in which the anatomical structures of arterial blood vessels are generated and organized. Arteries are blood vessels that transport blood from the heart to the body and its organs.
3 P15692 (/ISS) P15692 (/ISS) P15692 (/ISS)
Positive regulation of epithelial cell proliferation GO:0050679
Any process that activates or increases the rate or extent of epithelial cell proliferation.
3 P15692 (/ISS) P15692 (/ISS) P15692 (/ISS)
Positive regulation of positive chemotaxis GO:0050927
Any process that activates or increases the frequency, rate or extent of the directed movement of a motile cell or organism towards a higher concentration in a concentration gradient of a specific chemical.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Induction of positive chemotaxis GO:0050930
Any process that initiates the directed movement of a motile cell or organism towards a higher concentration in a concentration gradient of a specific chemical.
3 P15692 (/NAS) P15692 (/NAS) P15692 (/NAS)
Positive regulation of cellular component movement GO:0051272
Any process that activates or increases the frequency, rate or extent of the movement of a cellular component.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Positive regulation of focal adhesion assembly GO:0051894
Any process that activates or increases the frequency, rate or extent of focal adhesion assembly, the establishment and maturation of focal adhesions.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Primitive erythrocyte differentiation GO:0060319
Erythrocyte differentiation which occurs as part of the process of primitive hemopoiesis.
3 P15692 (/ISS) P15692 (/ISS) P15692 (/ISS)
Mammary gland alveolus development GO:0060749
The progression of the mammary gland alveolus over time, from its formation to its mature state. The mammary gland alveolus is a sac-like structure that is found in the mature gland.
3 P15692 (/ISS) P15692 (/ISS) P15692 (/ISS)
Cardiac vascular smooth muscle cell development GO:0060948
The process whose specific outcome is the progression of a cardiac vascular smooth muscle cell over time, from its formation to the mature state.
3 P15692 (/ISS) P15692 (/ISS) P15692 (/ISS)
Coronary artery morphogenesis GO:0060982
The process in which the anatomical structures of coronary arteries are generated and organized. Coronary arteries are blood vessels that transport blood to the heart muscle.
3 P15692 (/ISS) P15692 (/ISS) P15692 (/ISS)
Regulation of transcription from RNA polymerase II promoter in response to hypoxia GO:0061418
Any process that modulates the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of a hypoxia stimulus.
3 P15692 (/TAS) P15692 (/TAS) P15692 (/TAS)
Positive regulation of transcription from RNA polymerase II promoter in response to hypoxia GO:0061419
Any process that increases the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of a hypoxia stimulus.
3 P15692 (/IMP) P15692 (/IMP) P15692 (/IMP)
Dopaminergic neuron differentiation GO:0071542
The process in which a neuroblast acquires the specialized structural and functional features of a dopaminergic neuron, a neuron that secretes dopamine.
3 P15692 (/ISS) P15692 (/ISS) P15692 (/ISS)
Commissural neuron axon guidance GO:0071679
The process in which the migration of an axon growth cone of a commissural neuron is directed to its target in the brain in response to a combination of attractive and repulsive cues.
3 P15692 (/ISS) P15692 (/ISS) P15692 (/ISS)
Positive regulation of protein kinase C signaling GO:0090037
Any process that increases the frequency, rate, or extent of a series of reactions, mediated by the intracellular serine/threonine kinase protein kinase C, which occurs as a result of a single trigger reaction or compound.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Positive regulation of cell migration involved in sprouting angiogenesis GO:0090050
Any process that increases the frequency, rate or extent of cell migration involved in sprouting angiogenesis. Cell migration involved in sprouting angiogenesis is the orderly movement of endothelial cells into the extracellular matrix in order to form new blood vessels contributing to the process of sprouting angiogenesis.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Positive regulation of cell migration involved in sprouting angiogenesis GO:0090050
Any process that increases the frequency, rate or extent of cell migration involved in sprouting angiogenesis. Cell migration involved in sprouting angiogenesis is the orderly movement of endothelial cells into the extracellular matrix in order to form new blood vessels contributing to the process of sprouting angiogenesis.
3 P15692 (/IGI) P15692 (/IGI) P15692 (/IGI)
Positive regulation of cell migration involved in sprouting angiogenesis GO:0090050
Any process that increases the frequency, rate or extent of cell migration involved in sprouting angiogenesis. Cell migration involved in sprouting angiogenesis is the orderly movement of endothelial cells into the extracellular matrix in order to form new blood vessels contributing to the process of sprouting angiogenesis.
3 P15692 (/IMP) P15692 (/IMP) P15692 (/IMP)
Positive regulation of branching involved in ureteric bud morphogenesis GO:0090190
Any process that increases the rate, frequency or extent of branching involved in ureteric bud morphogenesis, the process in which the branching structure of the ureteric bud is generated and organized. The ureteric bud is an epithelial tube that grows out from the metanephric duct. The bud elongates and branches to give rise to the ureter and kidney collecting tubules.
3 P15692 (/ISS) P15692 (/ISS) P15692 (/ISS)
Regulation of retinal ganglion cell axon guidance GO:0090259
Any process that modulates the frequency, rate, or extent of retinal ganglion cell axon guidance, the process in which the migration of an axon growth cone of a retinal ganglion cell (RGC) is directed to its target in the brain in response to a combination of attractive and repulsive cues.
3 P15692 (/ISS) P15692 (/ISS) P15692 (/ISS)
Cellular stress response to acid chemical GO:0097533
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a disturbance in cellular homeostasis caused by the chemical structure of the anion portion of a dissociated acid (rather than the acid acting as a proton donor). The acid chemical may be in gaseous, liquid or solid form.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Positive regulation of peptidyl-tyrosine autophosphorylation GO:1900086
Any process that activates or increases the frequency, rate or extent of peptidyl-tyrosine autophosphorylation.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Positive regulation of p38MAPK cascade GO:1900745
Any process that activates or increases the frequency, rate or extent of p38MAPK cascade.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Positive regulation of histone deacetylase activity GO:1901727
Any process that activates or increases the frequency, rate or extent of histone deacetylase activity.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Positive regulation of retinal ganglion cell axon guidance GO:1902336
Any process that activates or increases the frequency, rate or extent of retinal ganglion cell axon guidance.
3 P15692 (/ISS) P15692 (/ISS) P15692 (/ISS)
Negative regulation of establishment of endothelial barrier GO:1903141
Any process that stops, prevents or reduces the frequency, rate or extent of establishment of endothelial barrier.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Negative regulation of adherens junction organization GO:1903392
Any process that stops, prevents or reduces the frequency, rate or extent of adherens junction organization.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Positive regulation of protein kinase D signaling GO:1903572
Any process that activates or increases the frequency, rate or extent of protein kinase D signaling.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis GO:1903589
Any process that activates or increases the frequency, rate or extent of blood vessel endothelial cell proliferation involved in sprouting angiogenesis.
3 P15692 (/IGI) P15692 (/IGI) P15692 (/IGI)
Positive regulation of sprouting angiogenesis GO:1903672
Any process that activates or increases the frequency, rate or extent of sprouting angiogenesis.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Positive regulation of sprouting angiogenesis GO:1903672
Any process that activates or increases the frequency, rate or extent of sprouting angiogenesis.
3 P15692 (/IGI) P15692 (/IGI) P15692 (/IGI)
Negative regulation of cell-cell adhesion mediated by cadherin GO:2000048
Any process that stops, prevents, or reduces the frequency, rate or extent of cell-cell adhesion mediated by cadherin.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Angiogenesis GO:0001525
Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
2 P16612 (/IMP) Q00731 (/IMP)
Blood vessel maturation GO:0001955
A developmental process, independent of morphogenetic (shape) change, that is required for a blood vessel to attain its fully functional state.
2 P67964 (/ISS) P67964 (/ISS)
Epicardial cell to mesenchymal cell transition GO:0003347
A transition where an epicardial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell. The epicardium is a part of the pericardium.
2 P67964 (/TAS) P67964 (/TAS)
Positive regulation of vascular permeability GO:0043117
Any process that increases the extent to which blood vessels can be pervaded by fluid.
2 P67964 (/ISS) P67964 (/ISS)
Positive chemotaxis GO:0050918
The directed movement of a motile cell or organism towards a higher concentration of a chemical.
2 P49151 (/ISS) P49151 (/ISS)
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
1 Q00731 (/ISO)
Angiogenesis GO:0001525
Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
1 Q00731 (/IGI)
Angiogenesis GO:0001525
Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
1 Q00731 (/ISO)
Angiogenesis GO:0001525
Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
1 P16612 (/TAS)
Ovarian follicle development GO:0001541
The process whose specific outcome is the progression of the ovarian follicle over time, from its formation to the mature structure.
1 Q00731 (/IMP)
Blood vessel development GO:0001568
The process whose specific outcome is the progression of a blood vessel over time, from its formation to the mature structure. The blood vessel is the vasculature carrying blood.
1 Q00731 (/IMP)
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
1 Q00731 (/ISO)
In utero embryonic development GO:0001701
The process whose specific outcome is the progression of the embryo in the uterus over time, from formation of the zygote in the oviduct, to birth. An example of this process is found in Mus musculus.
1 Q00731 (/IMP)
Kidney development GO:0001822
The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine.
1 Q00731 (/IMP)
Positive regulation of protein phosphorylation GO:0001934
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
1 Q00731 (/ISO)
Positive regulation of endothelial cell proliferation GO:0001938
Any process that activates or increases the rate or extent of endothelial cell proliferation.
1 Q00731 (/ISO)
Vasculature development GO:0001944
The process whose specific outcome is the progression of the vasculature over time, from its formation to the mature structure. The vasculature is an interconnected tubular multi-tissue structure that contains fluid that is actively transported around the organism.
1 Q00731 (/IMP)
Lymphangiogenesis GO:0001946
Lymph vessel formation when new vessels emerge from the proliferation of pre-existing vessels.
1 Q00731 (/IGI)
Blood vessel remodeling GO:0001974
The reorganization or renovation of existing blood vessels.
1 P16612 (/IMP)
Blood vessel remodeling GO:0001974
The reorganization or renovation of existing blood vessels.
1 Q00731 (/ISO)
Cell migration involved in sprouting angiogenesis GO:0002042
The orderly movement of endothelial cells into the extracellular matrix in order to form new blood vessels involved in sprouting angiogenesis.
1 Q00731 (/ISO)
Blood vessel endothelial cell proliferation involved in sprouting angiogenesis GO:0002043
The multiplication or reproduction of blood vessel endothelial cells, resulting in the expansion of a cell population contributing to sprouting angiogenesis.
1 Q00731 (/IMP)
Positive regulation of neuroblast proliferation GO:0002052
Any process that activates or increases the rate of neuroblast proliferation.
1 Q00731 (/IGI)
Positive regulation of receptor internalization GO:0002092
Any process that activates or increases the frequency, rate or extent of receptor internalization.
1 Q00731 (/ISO)
Basophil chemotaxis GO:0002575
The movement of a basophil in response to an external stimulus.
1 Q00731 (/ISO)
Heart morphogenesis GO:0003007
The developmental process in which the heart is generated and organized. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
1 Q00731 (/IMP)
Regulation of transcription by RNA polymerase II GO:0006357
Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.
1 Q00731 (/ISO)
Nervous system development GO:0007399
The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state.
1 P16612 (/IDA)
Nervous system development GO:0007399
The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state.
1 Q00731 (/ISO)
Nervous system development GO:0007399
The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state.
1 P16612 (/NAS)
Mesoderm development GO:0007498
The process whose specific outcome is the progression of the mesoderm over time, from its formation to the mature structure. The mesoderm is the middle germ layer that develops into muscle, bone, cartilage, blood and connective tissue.
1 Q00731 (/IMP)
Female pregnancy GO:0007565
The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth.
1 P16612 (/IEP)
Aging GO:0007568
A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700).
1 P16612 (/IEP)
Lactation GO:0007595
The regulated release of milk from the mammary glands and the period of time that a mother lactates to feed her young.
1 Q00731 (/IMP)
Cell population proliferation GO:0008283
The multiplication or reproduction of cells, resulting in the expansion of a cell population.
1 Q00731 (/IMP)
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
1 Q00731 (/ISO)
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
1 P16612 (/TAS)
Regulation of cell shape GO:0008360
Any process that modulates the surface configuration of a cell.
1 Q00731 (/ISO)
Response to cold GO:0009409
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cold stimulus, a temperature stimulus below the optimal temperature for that organism.
1 P16612 (/IEP)
Positive regulation of signal transduction GO:0009967
Any process that activates or increases the frequency, rate or extent of signal transduction.
1 P16612 (/IDA)
Positive regulation of signal transduction GO:0009967
Any process that activates or increases the frequency, rate or extent of signal transduction.
1 Q00731 (/ISO)
Positive regulation of endothelial cell migration GO:0010595
Any process that increases the rate, frequency, or extent of the orderly movement of an endothelial cell into the extracellular matrix to form an endothelium.
1 Q00731 (/ISO)
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
1 Q00731 (/ISO)
Negative regulation of gene expression GO:0010629
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
1 Q00731 (/IMP)
Negative regulation of gene expression GO:0010629
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
1 Q00731 (/ISO)
Negative regulation of epithelial to mesenchymal transition GO:0010719
Any process that decreases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
1 Q00731 (/IMP)
Regulation of nitric oxide mediated signal transduction GO:0010749
Any process that modulates the rate, frequency or extent of nitric oxide mediated signal transduction. Nitric oxide mediated signal transduction is a series of molecular signals mediated by the detection of nitric oxide (NO).
1 Q00731 (/ISO)
Cell migration GO:0016477
The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms.
1 Q00731 (/IDA)
Cell migration GO:0016477
The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms.
1 Q00731 (/IGI)
Negative regulation of cell-cell adhesion GO:0022408
Any process that stops, prevents or reduces the rate or extent of cell adhesion to another cell.
1 Q00731 (/IGI)
Hyaluronan metabolic process GO:0030212
The chemical reactions and pathways involving hyaluronan, the naturally occurring anionic form of hyaluronic acid, any member of a group of glycosaminoglycans, the repeat units of which consist of beta-1,4 linked D-glucuronyl-beta-(1,3)-N-acetyl-D-glucosamine.
1 P16612 (/IEP)
Monocyte differentiation GO:0030224
The process in which a relatively unspecialized myeloid precursor cell acquires the specialized features of a monocyte.
1 Q00731 (/ISO)
Macrophage differentiation GO:0030225
The process in which a relatively unspecialized monocyte acquires the specialized features of a macrophage.
1 Q00731 (/ISO)
Lung development GO:0030324
The process whose specific outcome is the progression of the lung over time, from its formation to the mature structure. In all air-breathing vertebrates the lungs are developed from the ventral wall of the oesophagus as a pouch which divides into two sacs. In amphibians and many reptiles the lungs retain very nearly this primitive sac-like character, but in the higher forms the connection with the esophagus becomes elongated into the windpipe and the inner walls of the sacs become more and more divided, until, in the mammals, the air spaces become minutely divided into tubes ending in small air cells, in the walls of which the blood circulates in a fine network of capillaries. In mammals the lungs are more or less divided into lobes, and each lung occupies a separate cavity in the thorax.
1 Q00731 (/IMP)
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
1 Q00731 (/ISO)
Epithelial cell differentiation GO:0030855
The process in which a relatively unspecialized cell acquires specialized features of an epithelial cell, any of the cells making up an epithelium.
1 Q00731 (/IMP)
Positive regulation of vascular endothelial growth factor receptor signaling pathway GO:0030949
Any process that activates or increases the frequency, rate or extent of vascular endothelial growth factor receptor signaling pathway activity.
1 Q00731 (/ISO)
Post-embryonic camera-type eye development GO:0031077
The process occurring during the post-embryonic phase whose specific outcome is the progression of the camera-type eye over time, from its formation to the mature structure.
1 Q00731 (/IMP)
Positive regulation of protein complex assembly GO:0031334
Any process that activates or increases the frequency, rate or extent of protein complex assembly.
1 Q00731 (/ISO)
Positive regulation of protein autophosphorylation GO:0031954
Any process that activates or increases the frequency, rate or extent of the phosphorylation by a protein of one or more of its own residues.
1 Q00731 (/ISO)
Activation of protein kinase activity GO:0032147
Any process that initiates the activity of an inactive protein kinase.
1 Q00731 (/ISO)
Response to estradiol GO:0032355
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen.
1 P16612 (/IEP)
Response to progesterone GO:0032570
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a progesterone stimulus.
1 P16612 (/IEP)
Positive regulation of CREB transcription factor activity GO:0032793
Any process that activates or increases the frequency, rate or extent of activity of the transcription factor CREB.
1 Q00731 (/ISO)
Positive regulation of peptidyl-serine phosphorylation GO:0033138
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine.
1 Q00731 (/ISO)
Response to vitamin A GO:0033189
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin A stimulus.
1 P16612 (/IEP)
Tube formation GO:0035148
Creation of the central hole of a tube in an anatomical structure through which gases and/or liquids flow.
1 Q00731 (/ISO)
Cellular response to drug GO:0035690
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
1 P16612 (/IEP)
Endothelial cell chemotaxis GO:0035767
The directed movement of an endothelial cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis).
1 Q00731 (/ISO)
Cellular response to vascular endothelial growth factor stimulus GO:0035924
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vascular endothelial growth factor stimulus.
1 Q00731 (/IGI)
Cellular response to vascular endothelial growth factor stimulus GO:0035924
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vascular endothelial growth factor stimulus.
1 Q00731 (/ISO)
Positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway GO:0038033
A series of molecular signals initiated by the binding of a vascular endothelial growth factor (VEGF) to a VEGFR on the surface of a cell, which activates or increases the frequency, rate or extent of endothelial cell chemotaxis.
1 Q00731 (/ISO)
Vascular endothelial growth factor signaling pathway GO:0038084
A series of molecular signals initiated by the binding of a vascular endothelial growth factor (VEGF) to a receptor on the surface of the target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
1 Q00731 (/ISO)
Positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway GO:0038091
A series of molecular signals initiated by the binding of a vascular endothelial growth factor (VEGF) to a platelet-derived growth factor receptor (PDGFR) on the surface of a cell, which activates or increases the frequency, rate or extent of cell proliferation.
1 Q00731 (/ISO)
VEGF-activated neuropilin signaling pathway GO:0038190
A series of molecular signals initiated by the binding of vascular endothelial growth factor (VEGF) to a neuropilin protein on the surface of a target cell, followed by transmission of the signal, and ending with regulation of a downstream cellular process, e.g. transcription.
1 Q00731 (/ISO)
Regulation of growth GO:0040008
Any process that modulates the frequency, rate or extent of the growth of all or part of an organism so that it occurs at its proper speed, either globally or in a specific part of the organism's development.
1 Q00731 (/IMP)
Wound healing GO:0042060
The series of events that restore integrity to a damaged tissue, following an injury.
1 P16612 (/IEP)
T-helper 1 type immune response GO:0042088
An immune response which is associated with resistance to intracellular bacteria, fungi, and protozoa, and pathological conditions such as arthritis, and which is typically orchestrated by the production of particular cytokines by T-helper 1 cells, most notably interferon-gamma, IL-2, and lymphotoxin.
1 P16612 (/IDA)
T-helper 1 type immune response GO:0042088
An immune response which is associated with resistance to intracellular bacteria, fungi, and protozoa, and pathological conditions such as arthritis, and which is typically orchestrated by the production of particular cytokines by T-helper 1 cells, most notably interferon-gamma, IL-2, and lymphotoxin.
1 Q00731 (/ISO)
Positive regulation of phosphorylation GO:0042327
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to a molecule.
1 Q00731 (/ISO)
Eye photoreceptor cell development GO:0042462
Development of a photoreceptor, a sensory cell in the eye that reacts to the presence of light. They usually contain a pigment that undergoes a chemical change when light is absorbed, thus stimulating a nerve.
1 Q00731 (/IMP)
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
1 Q00731 (/ISO)
Negative regulation of programmed cell death GO:0043069
Any process that stops, prevents, or reduces the frequency, rate or extent of programmed cell death, cell death resulting from activation of endogenous cellular processes.
1 P16612 (/IMP)
Negative regulation of programmed cell death GO:0043069
Any process that stops, prevents, or reduces the frequency, rate or extent of programmed cell death, cell death resulting from activation of endogenous cellular processes.
1 Q00731 (/ISO)
Positive regulation of vascular permeability GO:0043117
Any process that increases the extent to which blood vessels can be pervaded by fluid.
1 P16612 (/IMP)
Positive regulation of vascular permeability GO:0043117
Any process that increases the extent to which blood vessels can be pervaded by fluid.
1 Q00731 (/ISO)
Surfactant homeostasis GO:0043129
Any process involved in the maintenance of a steady-state level of the surface-active lipoprotein mixture which coats the alveoli.
1 Q00731 (/IMP)
Negative regulation of cysteine-type endopeptidase activity involved in apoptotic process GO:0043154
Any process that stops, prevents, or reduces the frequency, rate or extent of a cysteine-type endopeptidase activity involved in the apoptotic process.
1 Q00731 (/ISO)
Positive regulation of MAP kinase activity GO:0043406
Any process that activates or increases the frequency, rate or extent of MAP kinase activity.
1 Q00731 (/ISO)
Positive regulation of blood vessel endothelial cell migration GO:0043536
Any process that activates or increases the frequency, rate or extent of the migration of the endothelial cells of blood vessels.
1 Q00731 (/ISO)
Endothelial cell migration GO:0043542
The orderly movement of an endothelial cell into the extracellular matrix to form an endothelium.
1 Q00731 (/IMP)
Cellular response to fibroblast growth factor stimulus GO:0044344
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an fibroblast growth factor stimulus.
1 P16612 (/IEP)
Negative regulation of fat cell differentiation GO:0045599
Any process that stops, prevents, or reduces the frequency, rate or extent of adipocyte differentiation.
1 Q00731 (/IMP)
Regulation of endothelial cell differentiation GO:0045601
Any process that modulates the frequency, rate or extent of endothelial cell differentiation.
1 Q00731 (/IDA)
Positive regulation of osteoblast differentiation GO:0045669
Any process that activates or increases the frequency, rate or extent of osteoblast differentiation.
1 Q00731 (/IMP)
Positive regulation of angiogenesis GO:0045766
Any process that activates or increases angiogenesis.
1 Q00731 (/ISO)
Negative regulation of bone resorption GO:0045779
Any process that stops, prevents, or reduces the frequency, rate or extent of bone resorption.
1 P16612 (/IMP)
Negative regulation of bone resorption GO:0045779
Any process that stops, prevents, or reduces the frequency, rate or extent of bone resorption.
1 Q00731 (/ISO)
Positive regulation of cell adhesion GO:0045785
Any process that activates or increases the frequency, rate or extent of cell adhesion.
1 Q00731 (/ISO)
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
1 Q00731 (/ISO)
Vascular endothelial growth factor receptor signaling pathway GO:0048010
Any series of molecular signals initiated by the binding of an extracellular ligand to a vascular endothelial growth factor receptor (VEGFR) located on the surface of the receiving cell, and ending with regulation of a downstream cellular process, e.g. transcription.
1 P16612 (/IMP)
Vascular endothelial growth factor receptor signaling pathway GO:0048010
Any series of molecular signals initiated by the binding of an extracellular ligand to a vascular endothelial growth factor receptor (VEGFR) located on the surface of the receiving cell, and ending with regulation of a downstream cellular process, e.g. transcription.
1 Q00731 (/ISO)
MRNA stabilization GO:0048255
Prevention of degradation of mRNA molecules. In the absence of compensating changes in other processes, the slowing of mRNA degradation can result in an overall increase in the population of active mRNA molecules.
1 P16612 (/IDA)
MRNA stabilization GO:0048255
Prevention of degradation of mRNA molecules. In the absence of compensating changes in other processes, the slowing of mRNA degradation can result in an overall increase in the population of active mRNA molecules.
1 Q00731 (/ISO)
Lung alveolus development GO:0048286
The process whose specific outcome is the progression of the alveolus over time, from its formation to the mature structure. The alveolus is a sac for holding air in the lungs; formed by the terminal dilation of air passageways.
1 P16612 (/IMP)
Lung alveolus development GO:0048286
The process whose specific outcome is the progression of the alveolus over time, from its formation to the mature structure. The alveolus is a sac for holding air in the lungs; formed by the terminal dilation of air passageways.
1 Q00731 (/ISO)
Cell maturation GO:0048469
A developmental process, independent of morphogenetic (shape) change, that is required for a cell to attain its fully functional state.
1 Q00731 (/IMP)
Blood vessel morphogenesis GO:0048514
The process in which the anatomical structures of blood vessels are generated and organized. The blood vessel is the vasculature carrying blood.
1 Q00731 (/IDA)
Blood vessel morphogenesis GO:0048514
The process in which the anatomical structures of blood vessels are generated and organized. The blood vessel is the vasculature carrying blood.
1 Q00731 (/IGI)
Blood vessel morphogenesis GO:0048514
The process in which the anatomical structures of blood vessels are generated and organized. The blood vessel is the vasculature carrying blood.
1 Q00731 (/IMP)
Camera-type eye morphogenesis GO:0048593
The process in which the anatomical structures of the eye are generated and organized. The camera-type eye is an organ of sight that receives light through an aperture and focuses it through a lens, projecting it on a photoreceptor field.
1 Q00731 (/IMP)
Positive regulation of smooth muscle cell proliferation GO:0048661
Any process that activates or increases the rate or extent of smooth muscle cell proliferation.
1 P16612 (/IMP)
Positive regulation of smooth muscle cell proliferation GO:0048661
Any process that activates or increases the rate or extent of smooth muscle cell proliferation.
1 Q00731 (/ISO)
Cardiac muscle fiber development GO:0048739
The process whose specific outcome is the progression of cardiac muscle fiber over time, from its formation to the mature structure.
1 Q00731 (/IMP)
Positive regulation of axon extension involved in axon guidance GO:0048842
Any process that activates, maintains or increases the frequency, rate or extent of axon extension involved in axon guidance.
1 Q00731 (/IMP)
Artery morphogenesis GO:0048844
The process in which the anatomical structures of arterial blood vessels are generated and organized. Arteries are blood vessels that transport blood from the heart to the body and its organs.
1 Q00731 (/IMP)
Homeostasis of number of cells within a tissue GO:0048873
Any biological process involved in the maintenance of the steady-state number of cells within a population of cells in a tissue.
1 Q00731 (/IMP)
Positive regulation of epithelial cell proliferation GO:0050679
Any process that activates or increases the rate or extent of epithelial cell proliferation.
1 Q00731 (/IMP)
Positive regulation of peptidyl-tyrosine phosphorylation GO:0050731
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine.
1 Q00731 (/ISO)
Positive chemotaxis GO:0050918
The directed movement of a motile cell or organism towards a higher concentration of a chemical.
1 Q00731 (/ISO)
Positive regulation of positive chemotaxis GO:0050927
Any process that activates or increases the frequency, rate or extent of the directed movement of a motile cell or organism towards a higher concentration in a concentration gradient of a specific chemical.
1 Q00731 (/ISO)
Induction of positive chemotaxis GO:0050930
Any process that initiates the directed movement of a motile cell or organism towards a higher concentration in a concentration gradient of a specific chemical.
1 Q00731 (/ISO)
Positive regulation of cellular component movement GO:0051272
Any process that activates or increases the frequency, rate or extent of the movement of a cellular component.
1 Q00731 (/ISO)
Response to folic acid GO:0051593
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a folic acid stimulus.
1 P16612 (/IEP)
Positive regulation of focal adhesion assembly GO:0051894
Any process that activates or increases the frequency, rate or extent of focal adhesion assembly, the establishment and maturation of focal adhesions.
1 Q00731 (/ISO)
Primitive erythrocyte differentiation GO:0060319
Erythrocyte differentiation which occurs as part of the process of primitive hemopoiesis.
1 Q00731 (/IMP)
Cell chemotaxis GO:0060326
The directed movement of a motile cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis).
1 P16612 (/IMP)
Cell chemotaxis GO:0060326
The directed movement of a motile cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis).
1 Q00731 (/ISO)
Bone trabecula formation GO:0060346
The process of creating a trabecula in the bone. A trabecula is a tissue element in the form of a small beam, strut or rod.
1 Q00731 (/IMP)
Lung vasculature development GO:0060426
The biological process whose specific outcome is the progression of a lung vasculature from an initial condition to its mature state. This process begins with the formation of the lung vasculature and ends with the mature structure. The lung vasculature is composed of the tubule structures that carry blood or lymph in the lungs.
1 Q00731 (/IMP)
Mammary gland alveolus development GO:0060749
The progression of the mammary gland alveolus over time, from its formation to its mature state. The mammary gland alveolus is a sac-like structure that is found in the mature gland.
1 Q00731 (/IMP)
Positive regulation of mast cell chemotaxis GO:0060754
Any process that increases the rate, frequency or extent of mast cell chemotaxis. Mast cell chemotaxis is the movement of a mast cell in response to an external stimulus.
1 Q00731 (/ISO)
Angiogenesis involved in coronary vascular morphogenesis GO:0060978
Blood vessel formation in the heart when new vessels emerge from the proliferation of pre-existing blood vessels.
1 P16612 (/IMP)
Angiogenesis involved in coronary vascular morphogenesis GO:0060978
Blood vessel formation in the heart when new vessels emerge from the proliferation of pre-existing blood vessels.
1 Q00731 (/ISO)
Positive regulation of transcription from RNA polymerase II promoter in response to hypoxia GO:0061419
Any process that increases the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of a hypoxia stimulus.
1 Q00731 (/ISO)
Bone trabecula morphogenesis GO:0061430
The process of shaping a trabecula in bone. A trabecula is a tissue element in the form of a small beam, strut or rod.
1 Q00731 (/IMP)
Positive regulation of ERK1 and ERK2 cascade GO:0070374
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
1 Q00731 (/ISO)
Response to oxygen levels GO:0070482
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus reflecting the presence, absence, or concentration of oxygen.
1 P16612 (/IEP)
Cellular response to hypoxia GO:0071456
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
1 Q00731 (/ISO)
Dopaminergic neuron differentiation GO:0071542
The process in which a neuroblast acquires the specialized structural and functional features of a dopaminergic neuron, a neuron that secretes dopamine.
1 Q00731 (/IGI)
Response to dexamethasone GO:0071548
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a dexamethasone stimulus.
1 P16612 (/IEP)
Cellular response to dexamethasone stimulus GO:0071549
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a dexamethasone stimulus.
1 P16612 (/IEP)
Commissural neuron axon guidance GO:0071679
The process in which the migration of an axon growth cone of a commissural neuron is directed to its target in the brain in response to a combination of attractive and repulsive cues.
1 Q00731 (/IMP)
Positive regulation of protein kinase C signaling GO:0090037
Any process that increases the frequency, rate, or extent of a series of reactions, mediated by the intracellular serine/threonine kinase protein kinase C, which occurs as a result of a single trigger reaction or compound.
1 Q00731 (/ISO)
Positive regulation of cell migration involved in sprouting angiogenesis GO:0090050
Any process that increases the frequency, rate or extent of cell migration involved in sprouting angiogenesis. Cell migration involved in sprouting angiogenesis is the orderly movement of endothelial cells into the extracellular matrix in order to form new blood vessels contributing to the process of sprouting angiogenesis.
1 Q00731 (/ISO)
Positive regulation of branching involved in ureteric bud morphogenesis GO:0090190
Any process that increases the rate, frequency or extent of branching involved in ureteric bud morphogenesis, the process in which the branching structure of the ureteric bud is generated and organized. The ureteric bud is an epithelial tube that grows out from the metanephric duct. The bud elongates and branches to give rise to the ureter and kidney collecting tubules.
1 Q00731 (/IDA)
Regulation of retinal ganglion cell axon guidance GO:0090259
Any process that modulates the frequency, rate, or extent of retinal ganglion cell axon guidance, the process in which the migration of an axon growth cone of a retinal ganglion cell (RGC) is directed to its target in the brain in response to a combination of attractive and repulsive cues.
1 Q00731 (/IMP)
Motor neuron migration GO:0097475
The orderly movement of a motor neuron from one site to another. A motor neuron is an efferent neuron that passes from the central nervous system or a ganglion toward or to a muscle and conducts an impulse that causes movement.
1 Q00731 (/IMP)
Cellular stress response to acid chemical GO:0097533
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a disturbance in cellular homeostasis caused by the chemical structure of the anion portion of a dissociated acid (rather than the acid acting as a proton donor). The acid chemical may be in gaseous, liquid or solid form.
1 Q00731 (/ISO)
Retina blood vessel maintenance GO:0097601
A retina homeostatic process preventing the degeneration of a retina blood vessel.
1 Q00731 (/IMP)
Positive regulation of cold-induced thermogenesis GO:0120162
Any process that activates or increases the frequency, rate or extent of cold-induced thermogenesis.
1 Q00731 (/IMP)
Positive regulation of peptidyl-tyrosine autophosphorylation GO:1900086
Any process that activates or increases the frequency, rate or extent of peptidyl-tyrosine autophosphorylation.
1 Q00731 (/ISO)
Positive regulation of p38MAPK cascade GO:1900745
Any process that activates or increases the frequency, rate or extent of p38MAPK cascade.
1 Q00731 (/ISO)
Negative regulation of neuron death GO:1901215
Any process that stops, prevents or reduces the frequency, rate or extent of neuron death.
1 P16612 (/IMP)
Negative regulation of neuron death GO:1901215
Any process that stops, prevents or reduces the frequency, rate or extent of neuron death.
1 Q00731 (/ISO)
Positive regulation of lymphangiogenesis GO:1901492
Any process that activates or increases the frequency, rate or extent of lymphangiogenesis.
1 Q00731 (/IDA)
Regulation of hematopoietic progenitor cell differentiation GO:1901532
Any process that modulates the frequency, rate or extent of hematopoietic progenitor cell differentiation.
1 Q00731 (/IDA)
Positive regulation of histone deacetylase activity GO:1901727
Any process that activates or increases the frequency, rate or extent of histone deacetylase activity.
1 Q00731 (/ISO)
Positive regulation of protein localization to early endosome GO:1902966
Any process that activates or increases the frequency, rate or extent of protein localization to early endosome.
1 Q00731 (/ISO)
Positive regulation of protein kinase D signaling GO:1903572
Any process that activates or increases the frequency, rate or extent of protein kinase D signaling.
1 Q00731 (/ISO)
Positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis GO:1903589
Any process that activates or increases the frequency, rate or extent of blood vessel endothelial cell proliferation involved in sprouting angiogenesis.
1 Q00731 (/ISO)
Positive regulation of sprouting angiogenesis GO:1903672
Any process that activates or increases the frequency, rate or extent of sprouting angiogenesis.
1 Q00731 (/ISO)
Positive regulation of DNA biosynthetic process GO:2000573
Any process that activates or increases the frequency, rate or extent of DNA biosynthetic process.
1 Q00731 (/ISO)

There are 22 GO terms relating to "cellular component"

The search results have been sorted with the annotations that are found most frequently at the top of the list. The results can be filtered by typing text into the search box at the top of the table.
GO Term Annotations Evidence
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
25 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(15 more)
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
23 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(13 more)
Secretory granule GO:0030141
A small subcellular vesicle, surrounded by a membrane, that is formed from the Golgi apparatus and contains a highly concentrated protein destined for secretion. Secretory granules move towards the periphery of the cell and upon stimulation, their membranes fuse with the cell membrane, and their protein load is exteriorized. Processing of the contained protein may take place in secretory granules.
23 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(13 more)
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
22 B2C4J6 (/ISS) C6KYY4 (/ISS) C6KYY4 (/ISS) F6XLT6 (/ISS) F7GAQ8 (/ISS) F7IHP8 (/ISS) G1K280 (/ISS) G1PQ79 (/ISS) G1QUN7 (/ISS) G1QUN7 (/ISS)
(12 more)
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
8 P15691 (/IDA) P15691 (/IDA) P15691 (/IDA) P15692 (/IDA) P15692 (/IDA) P15692 (/IDA) P16612 (/IDA) Q00731 (/IDA)
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
4 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA) Q00731 (/IDA)
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
3 P15692 (/TAS) P15692 (/TAS) P15692 (/TAS)
Cell-cell adherens junction GO:0005913
An adherens junction which connects a cell to another cell.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Secretory granule GO:0030141
A small subcellular vesicle, surrounded by a membrane, that is formed from the Golgi apparatus and contains a highly concentrated protein destined for secretion. Secretory granules move towards the periphery of the cell and upon stimulation, their membranes fuse with the cell membrane, and their protein load is exteriorized. Processing of the contained protein may take place in secretory granules.
3 P15692 (/IDA) P15692 (/IDA) P15692 (/IDA)
Extracellular matrix GO:0031012
A structure lying external to one or more cells, which provides structural support, biochemical or biomechanical cues for cells or tissues.
3 P15692 (/NAS) P15692 (/NAS) P15692 (/NAS)
Platelet alpha granule lumen GO:0031093
The volume enclosed by the membrane of the platelet alpha granule.
3 P15692 (/TAS) P15692 (/TAS) P15692 (/TAS)
Basement membrane GO:0005604
A collagen-containing extracellular matrix consisting of a thin layer of dense material found in various animal tissues interposed between the cells and the adjacent connective tissue. It consists of the basal lamina plus an associated layer of reticulin fibers.
1 P16612 (/IDA)
Basement membrane GO:0005604
A collagen-containing extracellular matrix consisting of a thin layer of dense material found in various animal tissues interposed between the cells and the adjacent connective tissue. It consists of the basal lamina plus an associated layer of reticulin fibers.
1 Q00731 (/ISO)
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
1 Q00731 (/HDA)
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
1 Q00731 (/ISO)
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
1 Q00731 (/IDA)
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
1 Q00731 (/ISO)
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
1 Q00731 (/ISO)
Secretory granule GO:0030141
A small subcellular vesicle, surrounded by a membrane, that is formed from the Golgi apparatus and contains a highly concentrated protein destined for secretion. Secretory granules move towards the periphery of the cell and upon stimulation, their membranes fuse with the cell membrane, and their protein load is exteriorized. Processing of the contained protein may take place in secretory granules.
1 Q00731 (/ISO)
Vesicle GO:0031982
Any small, fluid-filled, spherical organelle enclosed by membrane.
1 P16612 (/IDA)
Vesicle GO:0031982
Any small, fluid-filled, spherical organelle enclosed by membrane.
1 Q00731 (/ISO)